RetractionNotice of Retraction
Re: Phromnoi K, Reuter S, Sung B, Prasad S, Kannappan R, Yadav VR, Chanmahasathien W, Limtrakul P, and Aggarwal BB (2010) A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic agents. Mol Pharmacol 79:279–289; doi:10.1124/mol.110.067512
Molecular Pharmacology July 2016, 90 (1) 64; DOI: https://doi.org/10.1124/mol.115.067512retraction
Following an internal investigation, Figures 1 and 3 of the article referenced above have been found to contain unacceptable image manipulation. Molecular Pharmacology has retracted this article.
- Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
In this issue
RetractionNotice of Retraction
Re: Phromnoi K, Reuter S, Sung B, Prasad S, Kannappan R, Yadav VR, Chanmahasathien W, Limtrakul P, and Aggarwal BB (2010) A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic agents. Mol Pharmacol 79:279–289; doi:10.1124/mol.110.067512
Molecular Pharmacology July 1, 2016, 90 (1) 64; DOI: https://doi.org/10.1124/mol.115.067512retraction
RetractionNotice of Retraction
Re: Phromnoi K, Reuter S, Sung B, Prasad S, Kannappan R, Yadav VR, Chanmahasathien W, Limtrakul P, and Aggarwal BB (2010) A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic agents. Mol Pharmacol 79:279–289; doi:10.1124/mol.110.067512
Molecular Pharmacology July 1, 2016, 90 (1) 64; DOI: https://doi.org/10.1124/mol.115.067512retraction
Jump to section
Related Articles
Cited By...
More in this TOC Section
- Notice of Retraction: Acharya P, Chen J-J, Correia MA (2010) Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2α kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone. Mol Pharmacol 77(4):575–592; doi:10.1124/mol.109.061259.
- Notice of Retraction: Acharya P, Engel JC, Correia MA (2009) Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: A consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2α (eIF2α)-kinase (PERK) and general control nonderepressible-2 eIF2α kinase (GCN2), and global translational shutoff. Mol Pharmacol 76(3):503–515; DOI: https://doi.org/10.1124/mol.109.056002.
Similar Articles
Advertisement